Invesco Ltd. Ab Cellera Biologics Inc. Transaction History
Invesco Ltd.
- $516 Billion
- Q4 2024
A detailed history of Invesco Ltd. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Invesco Ltd. holds 11,253 shares of ABCL stock, worth $26,444. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,253
Previous 10,950
2.77%
Holding current value
$26,444
Previous $28,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ABCL
# of Institutions
165Shares Held
120MCall Options Held
233KPut Options Held
339K-
Baker Bros. Advisors LP New York, NY27.5MShares$64.7 Million0.89% of portfolio
-
Baillie Gifford & CO12.2MShares$28.8 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$25 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA7.93MShares$18.6 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX7.35MShares$17.3 Million6.4% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $670M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...